Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon deficiency syndrome.

S Levin, T Hahn

    Clinical and Experimental Immunology
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    A deficient interferon (IFN) system response in 5% of viral disease patients led to severe illness. Early IFN replacement therapy rapidly improved symptoms and promoted recovery in most treated individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of Rasmussen's syndrome with ganciclovir.

    Neurology·1996
    Same author

    Modified thioglycolate medium: a simple and reliable means for detection of Trichomonas vaginalis.

    Journal of clinical microbiology·1996
    Same author

    "Have you seen this?" Hypovolemic shock.

    Toxicologic pathology·1996
    Same author

    Use of regression analysis and flow cytometry for determining levels of mixed semiallogeneic immune chimerism.

    Journal of investigative surgery : the official journal of the Academy of Surgical Research·1996
    Same author

    Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin.

    The American journal of medicine·1996
    Same author

    Safeguards in embryo donation.

    Fertility and sterility·1996
    Same journal

    Could we discuss the molecular signature of immune dysregulation?

    Clinical and experimental immunology·2026
    Same journal

    The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

    Clinical and experimental immunology·2026
    Same journal

    PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

    Clinical and experimental immunology·2026
    Same journal

    Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

    Clinical and experimental immunology·2026
    Same journal

    Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

    Clinical and experimental immunology·2026
    Same journal

    Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

    Clinical and experimental immunology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Virology
    • Cellular Biology

    Background:

    • The interferon (IFN) system is a critical early defense against viral infections.
    • IFN activates immune mechanisms, inducing an antiviral state that limits viral replication.
    • IFN is produced by nucleated cells, including peripheral blood mononuclear cells (PBMC).

    Purpose of the Study:

    • To investigate the role of IFN system response in acute viral illnesses.
    • To identify patients with absent or deficient IFN response during viral infections.
    • To evaluate the efficacy of IFN therapy in such cases.

    Main Methods:

    • Studied 1,500 individuals with various illnesses.
    • Identified 15 cases (5% of acute viral disease patients) with absent/deficient IFN response.

    Related Experiment Videos

  • Assessed IFN levels, PBMC IFN production (IFN-alpha, IFN-gamma) in vitro, and antiviral state induction.
  • Administered IFN therapy to a subset of patients and monitored outcomes.

    • Main Results:

    • 15 patients exhibited absent or deficient IFN system response, with no detectable IFN and non-responsive PBMC.
    • These patients presented with severe, progressive, or fatal viral disease.
    • IFN therapy induced an antiviral state, stimulated PBMC IFN production, and led to rapid recovery in 7/9 treated patients.

    Conclusions:

    • A deficient IFN response is associated with severe viral disease.
    • Early IFN replacement therapy is beneficial for patients with absent or deficient IFN response.
    • Prompt initiation of IFN therapy can prevent irreversible cell and organ damage and promote recovery.